Cutting Edge: Recipient MHC Class II Expression Is Required to Achieve Long-Term Survival of Murine Cardiac Allografts After Costimulatory BlockadeAkira Yamada, Hugh Auchincloss, Mohamed H. Sayegh et al.|The Journal of Immunology|2001Cited by 123
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus ConferenceDipak Kotecha, Irina Savelieva, Günter Breithardt et al.|EP Europace|2018Cited by 115